<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03813355</url>
  </required_header>
  <id_info>
    <org_study_id>1708195</org_study_id>
    <secondary_id>2018-A02866-49</secondary_id>
    <nct_id>NCT03813355</nct_id>
  </id_info>
  <brief_title>Evaluation of tDCS Efficacy in Enduring Anorexia Nervosa</brief_title>
  <acronym>EVASTRAM</acronym>
  <official_title>Evaluation of tDCS Efficacy in Enduring Anorexia Nervosa : a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 20% of anorexia nervosa cases do not respond to conventional management&#xD;
      strategies: cognitive behavioral therapy, weight gain contract, drug treatments, etc ... -&#xD;
      whether they are applied outpatients or during very long hospitalizations. These situations&#xD;
      of chronic evolution are characterized by a high rate of mortality. Brain stimulation could&#xD;
      be an alternative therapy for these patients. tDCS (transcranial direct current stimulation)&#xD;
      is a non-invasive stimulation technique that has demonstrated beneficial effects in other&#xD;
      psychiatric conditions such as major depression or schizophrenia.&#xD;
&#xD;
      The objectives of the study will be to evaluate the efficacy of tDCS in anorexia nervosa&#xD;
      resistant to conventional treatments on weight gain, eating behavior, psychological and&#xD;
      nutritional behavioral scales, cognition, connectivity and brain activity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 21, 2020</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>weeks 8</time_frame>
    <description>Change in body mass index after stimulation sessions. Weight and Height will be combined to report BMI in kg/m^2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eating Disorder Inventory (EDI)</measure>
    <time_frame>weeks 8</time_frame>
    <description>Change in Eating Disorder Inventory scale after stimulation sessions&#xD;
EDI measures :&#xD;
Drive for thinness (score between 0-4)&#xD;
Bulimia (score between 0-5)&#xD;
Body dissatisfaction (score between 3-10)&#xD;
ineffectiveness (score between 0-6)&#xD;
Perfectionism (score between 0-5)&#xD;
Interpersonal Distrust (score between 0-6)&#xD;
Interoceptive awareness (score between 0-4)&#xD;
Maturity Fears (score between 0-6)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dutch Eating Behavior Questionnaire (DEBQ)</measure>
    <time_frame>weeks 8</time_frame>
    <description>Change in Dutch Eating Behavior Questionnaire (DEBQ) after stimulation sessions&#xD;
DEBQ measures :&#xD;
Restrained eating (score between 10-30)&#xD;
Emotional eating (score between 17-35)&#xD;
external eating (score between 20-40)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>weeks 8</time_frame>
    <description>Change in Beck Depression Inventory after stimulation sessions.&#xD;
BDI measures :&#xD;
No depression : score between 0-9&#xD;
midl depression or anxiety : score between 10-19&#xD;
moderate depression or anxiety : score between 20-25&#xD;
moderate to severe depression or anxiety : score between 26-29&#xD;
severe depression or anxiety : score between 30-40&#xD;
very severe depression or anxiety : score between 41-84</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>weeks 8</time_frame>
    <description>Change in State-Trait Anxiety Inventory (STAI) after stimulation sessions&#xD;
STAI measures :&#xD;
no anxiety : score between 0-19&#xD;
very low anxiety : score between 36-45&#xD;
low anxiety : score between 46-55&#xD;
moderate anxiety : score between 56-65&#xD;
high anxiety : score between 56-65&#xD;
very high anxiety : score greater than 65</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Active stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brain stimulation by Transcranial Direct Current Stimulation (tDCS) with active stimulations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Brain stimulation by Transcranial Direct Current Stimulation (tDCS) with inactive stimulations</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial Direct Current Stimulation (tDCS)</intervention_name>
    <description>transcranial Direct Current Stimulation (tDCS) during 20 sessions</description>
    <arm_group_label>Active stimulation</arm_group_label>
    <arm_group_label>Sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 anorexia nervosa&#xD;
             criteria&#xD;
&#xD;
          -  Body Mass Index (BMI) &lt; 17kg/m2&#xD;
&#xD;
          -  Conventional treatment failure over the last 12 months&#xD;
&#xD;
          -  Refusal or no indication of artificial nutrition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Artificial nutrition&#xD;
&#xD;
          -  Other chronic diseases&#xD;
&#xD;
          -  drug use (except tobacco)&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  Edinburgh score &lt; 14&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Massoubre, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Saint-Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine Massoubre, PhD</last_name>
    <phone>0477829390</phone>
    <email>catherine.massoubre@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bogdan Galusca, PhD</last_name>
    <email>bogdan.galusca@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre-Michel Llorca, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Pierre-Michel Llorca, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thierry Bougerol, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Thierry Bougerol, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvain Iceta</last_name>
    </contact>
    <investigator>
      <last_name>Sylvain Iceta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Massoubre, PhD</last_name>
      <email>catherine.massoubre@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Bogdan Galusca, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine Massoubre, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natacha Germain, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gwénaelle Belleton, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 20, 2018</study_first_submitted>
  <study_first_submitted_qc>January 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2019</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>brain stimulation</keyword>
  <keyword>Body Mass Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

